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Abstract
Background: A definitive psychiatric diagnosis can provide significant direction to patient
treatment strategies and will facilitate the identification of potential risks and qualification for
supportive resources. Psychiatric research programs that were initiated in the 1950s led to the
classification framework known as the Diagnostic and Statistical Manual (DSM) of Mental
Disorders. These guidelines provide physicians with the information that they need for the
appropriate diagnosis of major psychiatric conditions. While the DSM has had a large impact on
the practice of psychiatry, there are still no biological markers of these diseases. This has led to
the development of diverse assessment methods that can lead to inconsistent diagnoses.
Methods: A ten-day reflective assessment was completed prior to the selection of the Quality
Improvement (QI) topic. Three PICOT (patient, intervention, comparison, outcome, and time)
questions were developed following this assessment to identify gaps in current practice methods.
A literature review was then conducted. Current research guidelines that support the
implementation of a structured clinical interview as part of the diagnostic process were
identified. The Plan-Do-Study-Act method was used to establish a plan for implementation and
achieving goals. Initial evaluations and documented diagnoses provided to patients who were
evaluated during an earlier six-week period were reviewed for comparison purposes.
Intervention: The Structured Clinical Interview for DSM-5, Clinician Version (SCID-5-CV) is
the standard method used to diagnose psychiatric disorders. Patients between the ages of 18 and
65 years who were seeking an initial evaluation during the six-week study period were assessed
using the SCID-5-CV.
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Results: Nine patients met the initial eligibility criteria; two patients were ultimately excluded.
Ages ranged from 18 to 60 years old and included five females, two males. Data collected from
the seven evaluations using the SCID-5-CV were reviewed, analyzed, and documented.
Conclusion: Implementation of the SCID-5-CV into clinical practice improved diagnostic
accuracy and reduced the frequency of unspecified psychiatric diagnoses. Despite the time
barriers associated with its administration, the use of the SCID-5-CV provides clinicians with the
assurance that all DSM-5 criteria for each diagnosis are met. Benefits to the patients, including
more effective treatment responses and qualification for supportive resources were also
recognized.
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Use of a Structured Clinical Interview to Eliminate Unspecified Psychiatric Diagnoses
Problem Description
A thorough assessment is required as a primary step when formulating a diagnosis for
empirically supported healthcare treatments. The Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-V) is a crucial resource used by healthcare providers to diagnose
and determine the severity of both physical and psychological symptoms associated with
psychiatric disease (Newson et al., 2020). While various assessment tools have been developed
to assist Psychiatric Mental Health Nurse Practitioners (PMHNPs) with patient evaluations, the
Structured Clinical Interview for DSM-V, (SCID-V) is currently recommended by evidencebased guidelines (Brodey et al., 2018). The wide variety of assessment tools available for use by
mental health clinicians can lead to inconsistent care and may jeopardize future research efforts
(Davis et al., 2016).
Available Knowledge
SCID-V has been identified as the “gold standard” for assessing psychiatric illness
(Osório et al., 2019). This interviewing tool has strong clinical validity and inter-rater reliability
when performed by trained and knowledgeable mental health providers (Osório et al., 2019).
However, despite its proven efficacy, its implementation has been hindered in routine clinical
practice due because of the training requirements and the length of time needed for its
appropriate administration (Brodey et al., 2018). These barriers have led to the development of
diverse assessment tools to be used by mental health providers as part of the interview process
(Newson et al., 2020).
At this time, there are more than one hundred different questionnaires and interview
methods available to assess depression, anxiety, bipolar disorder, addiction, and other psychiatric
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disorders (Newson et al., 2020). A review of the 126 most commonly used psychiatric diseasespecific and trans-diagnostic tools currently in use revealed significant disparities in
recommended assessment methods (Newson et al., 2020). The lack of a consistent and
standardized diagnostic method had a substantial impact on the quality and quantity of data
collected (Duncan et al., 2019). In addition to the many diagnostic tools available, clinician bias,
knowledge, and preference for specific assessment tools resulted in inconsistent assessments
with respect to formal diagnosis, the severity of impairment, and level of functioning
(Zimmerman et al., 2018).
Rationale
The SCID-5-Clinician Version (CV) presents a semi-structured interview method that
guides the PMHNP through the diagnostic process (First et al., 2016). The structured interview
process provides the clinician with the information needed to identify and distinguish between
psychiatric disorders that are frequently presented in an outpatient setting (First et al., 2016). The
guided flow of the interview allows the clinician to address the diagnostic criteria necessary for
major DSM-5 diagnoses in a systematic fashion (First et al., 2016). The SCID-5-CV is
accompanied by a User’s Manual that can be used by a PMHNP to perform an effective and
efficient assessment (First et al., 2016). Supplementary interview questions, rationale, and study
cases are provided in the manual to ensure its proper use (First et al., 2016).
Specific Aims
The aim of this quality improvement (QI) project was to implement the use of the SCID5-CV in an outpatient mental health setting. The goal was to explore the impact of consistent use
of the SCID-5-CV during initial patient evaluations and specifically to determine whether
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implementation of this method results in the elimination or at least a decrease in documented
diagnoses listed as unspecified psychiatric disorders.
Methods
Context
The initial evaluation of participants aged 18 to 65 years was carried out at El Paso
Mental Health. El Paso Mental Health is a privately-owned outpatient mental health clinic with
more than 60 employees and three offices located within the United States at the Mexico border
(El Paso Mental Health – Restoring Balance for a Better Life, n.d.). This facility has served the
El Paso and San Antonio, Texas communities for over two years. Eight board-certified PMHNPs
are available to perform evaluations and medication management via in-person and telemedicine
appointments. Medications and/or case management have been provided to more than 2000
child, adolescent, adult, and geriatric patients. Therapy services are also provided based largely
on diagnosis and the severity of their psychiatric disorder (El Paso Mental Health, n.d.).
El Paso is located in southwest Texas at the border between the United States and Mexico
(Escobar et al., 2021). Depression and anxiety are highly prevalent in this population that
experiences significant disparities with respect to both medical and mental health care (Escobar
et al., 2021). The Texas border region has a high poverty rate and a shortage of mental health
providers; many patients lack insurance coverage (Escobar et al., 2021). As of May 2021, only
97 mental health providers were available in El Paso for every 100,000 residents (Mental Health
Provider Rate, 2022). Collectively, these factors lead to increased delays in obtaining appropriate
mental health treatment and services which can have a significant impact on an individual’s
health and safety.
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Intervention
The SCID-5-CV and User’s Manual were purchased and secured after project approval.
At the beginning of the intervention, an informative session was provided to the Office
Supervisor and the front staff. Additional SCID-5-CV and User’s Manuals were purchased for
the Office Supervisor and all PMHNPs interested in the interview process. Information was
provided on the purpose of this intervention and the process of performing the SCID-5-CV
during an initial evaluation. Continued engagement with the Office supervisor and front staff was
provided throughout the QI project.
The paper version of the SCID-5-CV was scanned and made available in an electronic
format. The SCID-5-CV form was duplicated for each patient that met the eligibility criteria. The
evaluation was performed, and the findings were saved and an individual .pdf was created for
each participant. Using this method, information for all eligible participants was documented,
reviewed, and placed in their electronic health records (EHRs).
Study of Intervention
The Plan-Do-Study-Act (PDSA) model was used to assess, analyze, and evaluate the
impact of the SCID-5-CV within a six-week study period. This tool may be most effective when
used to promote clinical improvements as it is highly adaptable to diverse clinical settings and
research-based interventions (Coury et al., 2017). The four stages of the PDSA approach are
included in a continuous process that permits changes in the implementation of an intervention to
reach the desired result (Coury et al., 2017). The PDSA model was applied to this QI project as
described in the paragraphs to follow.
Plan: A ten-day reflective practice was performed during working clinic hours during
which each patient encounter was documented. Encounters were grouped by patient age (minors,
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adults, or geriatric) and purpose of visit (initial evaluation or follow-up). The three PICOT
questions that follow were developed after identifying gaps in current research from practice
methods.
In adults ages 18 to 35 requesting an initial evaluation, how does blank compare to the
use of the PHQ 9, GAD 7 and MDQ by the PMHNP in the interview process affect the result of
non-specific psychiatric disorders being diagnosed within an hour?
In older adults ages 55 to 77 diagnosed with an anxiety disorder and being treated with
benzodiazepines, what is the effect of continuing benzodiazepine treatment on continued daily
anxiety compared to blank after two weeks?
In adults ages 18 to 35 with complaints of sleep disturbance, what is the effect of
Trazodone or OTC (over the counter) Melatonin treatment on continued difficulty with sleep
onset and maintenance compared with blank after four weeks?
After review, the research focus was directed towards a need for a change in the initial
evaluation process. During the ten-day reflective, eleven of the 16 adult patients who presented
for an initial evaluation were diagnosed with unspecified mood and/or anxiety disorders. A
review of the literature was performed to identify current evidence-based practices used to
perform psychiatric assessments as well as guidelines to assess depression, bipolar disorder, and
schizophrenia.
The SCID-5-CV was identified as empirically supported for use in patient evaluations.
Approval by the administration of El Paso Mental Health was required for this change in practice
within the organization. Eligibility criteria were established for participants and expected clinical
outcomes were developed. The User’s Manual for the SCID-5-CV and the interview format were
purchased and reviewed before their implementation.
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Do: To aid in its implementation, the SCID-5-CV was electronically scanned and
downloaded into the PMHNP-designated work electronic device. If a patient met eligibility
criteria, the SCID-5-CV was electronically duplicated for use. Information gathered during the
initial evaluation was electronically documented in the appropriate sections of the SCID-5-CV
and results were saved. A .pdf documenting the patient-specific interview was generated for
placement into the patients’ EHRs.
Study: Data collected were analyzed after the completion of the initial evaluation and
after the QI project implementation. The patients were provided with copies of the findings and
documentation of diagnoses that were included in the EHR. The study process also included a
review of the SCID-5-CV findings to ensure that DSM-5 criteria were met for the given
diagnosis. Possible barriers to implementation, for example, administration time and patient
adherence to interview instructions were also reviewed. Improved patient outcomes and approval
of supportive resources based on appropriate diagnosis were identified.
Act: The use of the SCID-5-CV facilitated the full elimination of non-specific psychiatric
diagnoses and ensured that the criteria for each specific diagnosis were met. The time required to
administer the SCID-5-CV was identified as the greatest obstacle to its implementation. After the
initial evaluation of the results of the QI project, recommendations to change the approach used
in the next PDSA cycle were made. Use of the NetSCID-5-CV, a web-based version of the
SCID-5-CV, was found to decrease the administration time by 30% (Brodey et al., 2018). The
benefits of the NetSCID-5-CV include immediate diagnostic reporting when criteria have been
met, guidance for the interviewer, and comprehensive diagnostic reporting (NETSCID-5, 2021).
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Measures
The primary intent of a QI project is to identify ways to improve healthcare outcomes via
the translation of research findings into the clinical setting. When combined with current
treatment guidelines, the practitioner can use a systematic approach in their attempt to facilitate
acceptance of the desired change. Quality measures must be instituted during the planning phase
of the project to ensure the appropriate data are collected and to determine if the desired goal has
been achieved.
The quality measures discussed in the paragraphs to follow were identified as a means to
improve both the clinical process and patient health outcomes.
Process Measure: All documented diagnoses will address DSM-5 criteria. This will
decrease the risk of clinician bias and the opportunity for mistaken and/or underdiagnosis.
Outcomes Measure: Empirically supported treatment will be provided by the PMHNP to
address the specific diagnosis.
Analysis
The findings collected during these six weeks were compared to those from patient
evaluations performed by the PMHNP during the same period in 2021. Six patients who
presented during this period in 2021 met the eligibility criteria. These six evaluations were
performed and completed using the Patient Health Questionnaire 9 (PHQ-9), Generalized
Anxiety Disorder 7 (GAD-7), and the Mood Disorder Questionnaire (MDQ). Four patients were
provided with unspecified psychiatric diagnoses after the interview. No changes were made upon
review of these findings one year later.
Nine participants met the eligibility criteria during the designated six-week period in
2022. Two participants were ultimately excluded. Seven evaluations were performed and
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completed using the SCID-5-CV. After the interview process, all seven participants were
provided with specific psychiatric diagnoses. These diagnoses were confirmed as meeting the
appropriate criteria upon subsequent review.
Ethical Considerations
Patient safety is always the first priority during diagnosis and treatment. A PMHNP may
recognize an acute psychiatric crisis once suicidal behavior and homicidal ideation are evident.
These findings require a rapid response from the provider. Telemedicine and in-person services
require different responses to ensure patient safety and may disrupt the completion of the
interview process. Patients who present an immediate risk to themselves or others during the
assessment process were excluded from this project. Proper actions were taken, and authorities
were notified as necessary.
Results
Nine patients who presented between January 17, 2022, and February 22, 2022, met the
eligibility criteria for this QI project. Two patients were excluded because they were unable to
participate and presented with an immediate risk to their safety. Of the seven participants, four
were evaluated via telemedicine, and three presented to the clinic in person. All seven
participants were provided with a specific psychiatric diagnosis at the end of their first evaluation
and the implementation of the SCID-5-CV. The time required to administer the SCID-5-CV
varied from 40 to 90 minutes. Individualized treatment plans focused on evidence-based
pharmacological and psychosocial approaches were provided according to the documented
diagnoses. Table 1 provides a list of diagnoses found during the intervention period.
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Table 1.
Mood Disorders
Major Depressive Disorder, single episode, mild F32.0
Major Depressive Disorder, single episode, moderate F32.1
Major Depressive Disorder, single episode, severe without psychotic features, F32.2
Major Depressive Disorder, recurrent, moderate F33.1
Major Depressive Disorder, recurrent severe, without psychotic features, F33.2
Dysthymic Disorder, F34.1
Anxiety Disorders
Generalized anxiety disorder, F41.1
Post-traumatic stress disorder, chronic F43.12
Panic Disorder (episodic paroxysmal anxiety) F41.0
Substance Use Disorders
Alcohol dependence with withdraw, with perceptual disturbance F10.232
Cocaine use disorder, moderate in early remission F14.11

Discussion
Summary
The use of variable assessment methods can lead to the collection of poor-quality data.
To decrease the potential for diagnostic error, high-quality diagnostic tools need to be used in
routine clinical practice (Clark et al., 2019). Most clinical guidelines recommend the use of the
SCIV-5 for formal individual assessments. Evidence-based pharmacological interventions and
education tailored to the nature of the specific diagnosis are critical to providing the patient with
efficient and effective healthcare.
The focus of this QI project was to implement the recommended diagnostic tool in an
outpatient psychiatric setting during the initial evaluation. In this project, the SCIV-5-CV was
implemented for the assessment of adults aged 18 to 65 who were able to respond independently
to each of the interview questions. The use of the SCID-5-CV to assess these seven patients
resulted in no unspecified psychiatric diagnoses after the initial evaluations. Other patient
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outcomes were noted, including diminished barriers regarding qualification for supportive
services. Based on the significant benefits observed, the use of the SCID-5-CV will continue and
will be encouraged in daily clinical practice.
Interpretation
The SCID-5-CV is an important tool for the assessment of adults presenting with a
potential psychiatric illness. The use of this semi-structured interview helps the PMHNP to
ensure that current DSM criteria are met before formal diagnosis and to create individualized
treatment recommendations. However, the time required to perform this evaluation may present
barriers to its clinical use. The use of the electronic version, NetSCID-5-CV, may ultimately
improve clinicians’ adherence to evidence-based assessment and treatment guidelines.
Limitations
No validated Spanish version of the SCID-5-CV is currently available. The English
version of the SCID-5-CV used in this study was translated into Spanish by the doctoral student.
Although a Spanish heritage speaker, the level of proficiency of the doctoral student has not been
formally assessed. Bilingual provider certification was not obtained.
Conclusion
Consistent and appropriate psychiatric diagnosis is largely dependent on the information
provided during the assessment, the nature of current symptoms, and the accuracy and reliability
of the diagnostic method used (Tas & Ozusta, 2019). Patient follow-up should focus on
confirmation or clarification of the documented diagnosis if not already specified (Tas & Ozusta,
2019). The absence of consistent measures may result in variable diagnoses and treatment
recommendations that have a substantial impact on patient outcomes (Tas & Ozusta, 2019).
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